Search research articles
Contact Us
Filters
Showing results (71-80 of 120) with videos related to
Page
of 12
Sort By:
Obstetrics and Gynecology
|
November 1, 1988
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women
G B Melis, M Gambacciani, A Cagnacci, et al.
Obstetrics and Gynecology
|
March 1, 1988
Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline
G B Melis, V Mais, A M Paoletti, et al.
Maturitas
|
October 1, 1986
Effects of different dopamine agonists and antagonists on post-menopausal hot flushes
L Zichella, P Falaschi, P Fioretti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1993
The relative contributions of menopause and aging to postmenopausal vertebral osteopenia
M Gambacciani, A Spinetti, L de Simone, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
April 27, 2004
A longitudinal evaluation of the effect of two doses of tibolone on bone density and metabolism in early postmenopausal women
M Gambacciani, M Ciaponi, B Cappagli, et al.
Climacteric : the Journal of the International Menopause Society
|
October 30, 2020
Safety of vaginal erbium laser: A review of 113,000 patients treated in the past 8 years
M Gambacciani, M Cervigni, A Gaspar, et al.
Journal of Endocrinological Investigation
|
May 1, 1993
Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women
M Gambacciani, A Spinetti, B Cappagli, et al.
Clinical Endocrinology
|
November 1, 1989
Influence of oestradiol and progesterone on pulsatile LH secretion in postmenopausal women
A Cagnacci, G B Melis, A M Paoletti, et al.
Journal of Endocrinological Investigation
|
November 1, 1992
Lack of any estrogenic effect of ipriflavone in postmenopausal women
G B Melis, A M Paoletti, A Cagnacci, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1987
Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women
G B Melis, M Gambacciani, A M Paoletti, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 120) with videos related to
Sort By:
Page
of 12
Obstetrics and Gynecology
|
November 1, 1988
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women
G B Melis, M Gambacciani, A Cagnacci, et al.
Obstetrics and Gynecology
|
March 1, 1988
Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline
G B Melis, V Mais, A M Paoletti, et al.
Maturitas
|
October 1, 1986
Effects of different dopamine agonists and antagonists on post-menopausal hot flushes
L Zichella, P Falaschi, P Fioretti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1993
The relative contributions of menopause and aging to postmenopausal vertebral osteopenia
M Gambacciani, A Spinetti, L de Simone, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
April 27, 2004
A longitudinal evaluation of the effect of two doses of tibolone on bone density and metabolism in early postmenopausal women
M Gambacciani, M Ciaponi, B Cappagli, et al.
Climacteric : the Journal of the International Menopause Society
|
October 30, 2020
Safety of vaginal erbium laser: A review of 113,000 patients treated in the past 8 years
M Gambacciani, M Cervigni, A Gaspar, et al.
Journal of Endocrinological Investigation
|
May 1, 1993
Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women
M Gambacciani, A Spinetti, B Cappagli, et al.
Clinical Endocrinology
|
November 1, 1989
Influence of oestradiol and progesterone on pulsatile LH secretion in postmenopausal women
A Cagnacci, G B Melis, A M Paoletti, et al.
Journal of Endocrinological Investigation
|
November 1, 1992
Lack of any estrogenic effect of ipriflavone in postmenopausal women
G B Melis, A M Paoletti, A Cagnacci, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1987
Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women
G B Melis, M Gambacciani, A M Paoletti, et al.
Page
of 12